APOG vs SWBI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
APOG demonstrates strong deterministic health with a Piotroski F-Score of 7/9, indicating solid operational efficiency and financial stability, though the absence of an Altman Z-Score raises concern about default risk. The stock trades at a premium to its Graham Number ($31.67) and intrinsic value ($13.09), suggesting overvaluation despite a relatively low P/E (17.79) and attractive forward P/E (10.48). However, the company faces significant headwinds with negative year-over-year earnings growth (-19.8%) and a deteriorating technical trend (0/100), while insider activity remains neutral. Analysts show no consensus, and the 1-year price decline of 26.6% reflects persistent market skepticism.
SWBI exhibits a concerning disconnect between its market price ($14.85) and its deterministic fair value, with a Graham Number of $6.64 and Intrinsic Value of $7.08. While the Piotroski F-Score of 4/9 indicates stable financial health and growth metrics are strong, the valuation is stretched with a P/E of 61.88. Most critically, the dividend payout ratio of 216.67% is fundamentally unsustainable. Despite strong 1-year price momentum, the technical trend has turned sharply bearish (10/100), suggesting a correction toward fair value is likely.
Compare Another Pair
Related Comparisons
APOG vs SWBI: Head-to-Head Comparison
This page compares Apogee Enterprises, Inc. (APOG) and Smith & Wesson Brands, Inc. (SWBI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.